
Auteur M. P. SCHAUB
|
Documents disponibles écrits par cet auteur (9)

F. BÉEN ; L. BIJLSMA ; L. BENAGLIA ; J. D. BERSET ; A. M. BOTERO-COY ; S. CASTIGLIONI ; L. KRAUS ; F. ZOBEL ; M. P. SCHAUB ; A. BUCHELI ; F. HERNANDEZ ; O. DELEMONT ; P. ESSEIVA ; C. ORT | 2016
Dans Drug and Alcohol Dependence (Vol.161, April 2016) Article : PériodiqueBackground: Wastewater analysis is an innovative approach that allows monitoring illicit drug use at the community level. This study focused on investigating geographical differences in drug consumption by comparing epidemiological, crime and wa[...]
M. ARGOTE ; G. SESCOUSSE ; J. BRUNELIN ; G. BAUDIN ; M. P. SCHAUB ; R. RABIN ; T. SCHNELL ; P. A. RINGEN ; O. A. ANDREASSEN ; J. M. ADDINGTON ; P. BRAMBILLA ; G. DELVECCHIO ; A. BECHDOLF ; T. WOBROCK ; T. SCHNEIDER-AXMANN ; D. HERZIG ; C. MOHR ; R. VILA-BADIA ; J. U. RODIE ; J. MALLET ; V. RICCI ; G. MARTINOTTI ; K. KNIZKOVA ; M. RODRIGUEZ ; J. COOKEY ; P. TIBBO ; F. SCHEFFLER ; L. ASMAL ; C. GARCIA-RIZO ; S. AMORETTI ; C. HUBER ; H. THIBEAU ; E. KLINE ; E. FAKRA ; R. JARDRI ; M. NOURREDINE ; B. ROLLAND | 2023
Dans EClinicalMedicine (Vol.64, October 2023) Article : PériodiqueFRANÇAIS : Des chercheurs de plusieurs pays européens, américains et africains ont réalisé une méta-analyse sur l'association entre la consommation de cannabis et la schizophrénie. Ils ont conclu que les résultats ne permettaient pas de détermi[...]
M. P. SCHAUB ; A. UCHTENHAGEN ; EQUS Expert Group | 2013
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : PériodiqueBackground/Aims: The Study on the Development of an EU Framework for Minimum Quality Standards and Benchmarks in Drug Demand Reduction (EQUS) has set up an inventory of quality standards and initiated a consensus-building process, aiming at esta[...]
M. P. SCHAUB ; L. J. MAIER ; A. WENGER ; L. STARK ; O. BERG ; T. BECK ; B. B. QUEDNOW ; S. HAUG | 2015
Dans BMC Psychiatry (Vol.15, n°156, 10 July 2015) Article : PériodiqueBACKGROUND: Web-based self-help interventions that aim to reduce problematic substance use are able to reach "hidden" consumer groups in the general population who often fear stigmatization and thus avoid institutional addiction treatment. In We[...]
N. BOUMPARIS ; E. KARYOTAKI ; M. P. SCHAUB ; P. CUIJPERS ; H. RIPER | 2017
Dans Addiction (Vol.112, n°9, September 2017) Article : PériodiqueCommentary: It works, but only if they use it - addressing treatment adherence and attrition in internet interventions for illicit substance use. Stockings E.A., p. 1533-1534. Background and Aims: Research has shown that internet intervention[...]
This paper presents results from a scoping study on the availability of smartphone-based applications in the drugs field within a European and global context. It explores the range of m-health applications available to users and professionals s[...]
L. J. MAIER ; S. HAUG ; M. P. SCHAUB | 2016
Dans Addiction (Vol.111, n°2, February 2016) Article : PériodiqueAims: To estimate the prevalence of self-reported pharmacological neuroenhancement (PNE) with prescription or recreational drugs among the Swiss general population and correlates of PNE. Design: A population-based cross-sectional study using a [...]
N. BOUMPARIS ; L. LOHEIDE-NIESMANN ; M. BLANKERS ; D. D. EBERT ; D. KORF ; M. P. SCHAUB ; R. SPIJKERMAN ; R. J. TAIT ; H. RIPER | 2019
Dans Drug and Alcohol Dependence (Vol.200, July 2019) Article : PériodiqueBackground: Frequent Cannabis use has been linked to a variety of negative mental, physical, and social consequences. We assessed the effects of digital prevention and treatment interventions on Cannabis use reduction in comparison with control [...]
E. LIAKONI ; M. P. SCHAUB ; L. J. MAIER ; G. V. GLAUSER ; M. E. LIECHTI | 2015
Dans PLOS ONE (Vol.10, n°10, October 2015) Article : PériodiqueThe use of prescription or recreational drugs for cognitive enhancement (CE) is prevalent among students. However, the prevalence of CE among Swiss school students is unknown. We therefore performed a cross-sectional online survey including > = [...]